These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5452494)

  • 61. Modifying proteins.
    Nat New Biol; 1971 Apr; 230(16):228. PubMed ID: 5280400
    [No Abstract]   [Full Text] [Related]  

  • 62. AN EXTRACTABLE AGENT, INDUCED IN UNINFECTED TISSUES BY LOCALIZED VIRUS INFECTIONS, THAT INTERFERES WITH INFECTION BY TOBACCO MOSAIC VIRUS.
    LOEBENSTEIN G; ROSS AF
    Virology; 1963 Jul; 20():507-17. PubMed ID: 14043416
    [No Abstract]   [Full Text] [Related]  

  • 63. Immunochemical studies on the tobacco mosaic virus protein. 8. Solid-phase synthesis and immunological activity of peptides related to an antigenic areaof tobacco mosaic virus protein.
    Young JD; Benjamini E; Leung CY
    Biochemistry; 1968 Sep; 7(9):3113-9. PubMed ID: 5684338
    [No Abstract]   [Full Text] [Related]  

  • 64. Tobacco mosaic virus movement protein associates with the cytoskeleton in tobacco cells.
    McLean BG; Zupan J; Zambryski PC
    Plant Cell; 1995 Dec; 7(12):2101-14. PubMed ID: 8718621
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Primary protein structure of strains of tobacco mosaic virus. IV. Amino acid sequences (1 to 61 and 135 to 158) of proteins of tobacco mosaic virus strain U2].
    Wittmann HG
    Z Naturforsch B; 1965 Dec; 20(12):1213-23. PubMed ID: 4381390
    [No Abstract]   [Full Text] [Related]  

  • 66. Location of tyrosine residues in the disk of tobacco-mosaic-virus protein and comparison of the subunit packing with that of the virus.
    Graham J; Butler PJ
    Eur J Biochem; 1978 Feb; 83(2):523-8. PubMed ID: 631133
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Comparison of the antigenic properties of a protein polymerized by the types of spiral and cylindrical symmetry].
    Kapitsa OS; Andreeva EN
    Izv Akad Nauk SSSR Biol; 1974; (5):650-7. PubMed ID: 4142880
    [No Abstract]   [Full Text] [Related]  

  • 68. Structural repeats and evolution of tobacco mosaic virus coat protein and RNA.
    McLachlan AD; Bloomer AC; Butler PJ
    J Mol Biol; 1980 Jan; 136(3):203-24. PubMed ID: 6768892
    [No Abstract]   [Full Text] [Related]  

  • 69. Protein and virus crystal growth on international microgravity laboratory-2.
    Koszelak S; Day J; Leja C; Cudney R; McPherson A
    Biophys J; 1995 Jul; 69(1):13-9. PubMed ID: 7669890
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A proteinless mutant of tobacco mosaic virus: evidence against the role of a viral coat protein for interference.
    Sarkar S; Smitamana P
    Mol Gen Genet; 1981; 184(1):158-9. PubMed ID: 6950193
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [RESEARCH ON DISSOLVED TOBACCO MOSAIC VIRUS PROTEIN WITH ROENTGEN SMALL ANGLE SCATTER USING ABSOLUTE INTENSITY].
    ANDERER FA; KRATKY O; LO R
    Z Naturforsch B; 1964 Oct; 19():906-16. PubMed ID: 14324023
    [No Abstract]   [Full Text] [Related]  

  • 72. [ACTION OF SUPRA-OPTIMAL TEMPERATURES ON MULTIPLICATION OF THE TOBACCO MOSAIC VIRUS IN LEAF DISKS ARRANGED IN LIQUID MEDIUM].
    LEBEURIER G; HIRTH L
    C R Hebd Seances Acad Sci; 1964 Oct; 259():2563-6. PubMed ID: 14214222
    [No Abstract]   [Full Text] [Related]  

  • 73. Synthesis of tobacco mosaic virus in intact tobacco leaves systemically inoculated by differential temperature treatment.
    Dawson WO; Schlegel DE; Lung MC
    Virology; 1975 Jun; 65(2):565-73. PubMed ID: 1129951
    [No Abstract]   [Full Text] [Related]  

  • 74. SYMPTOMS AND CYTOLOGY OF LIVING CELLS INFECTED WITH DEFECTIVE MUTANTS OF TOBACCO MOSAIC VIRUS.
    BALD JG
    Virology; 1964 Mar; 22():388-96. PubMed ID: 14127836
    [No Abstract]   [Full Text] [Related]  

  • 75. Structure and synthesis of a lipid-containing bacteriophage. XXVI. Neutron small angle scattering on bacteriophage PM2.
    Schneider D; Zulauf M; Schäfer R; Franklin RM
    J Mol Biol; 1978 Sep; 124(1):97-122. PubMed ID: 712838
    [No Abstract]   [Full Text] [Related]  

  • 76. EFFECT OF 5-FLUOROURACIL ON ANTIGENIC PROPERTIES OF TOBACCO MOSAIC VIRUS.
    SUTI'C D; DJORDJEVIC B
    Nature; 1964 Jul; 203():434-5. PubMed ID: 14197409
    [No Abstract]   [Full Text] [Related]  

  • 77. ELECTRON MICROSCOPY OF PARTIALLY DEGRADED TOBACCO MOSAIC VIRUS.
    CORBETT MK
    Virology; 1964 Apr; 22():539-43. PubMed ID: 14166112
    [No Abstract]   [Full Text] [Related]  

  • 78. Structures and roles of the polymorphic forms of tobacco mosaic virus. V. Conservation of the abnormally titrating groups in tobacco mosaic virus.
    Butler PJ; Durham AC
    J Mol Biol; 1972 Dec; 72(1):19-24. PubMed ID: 4648113
    [No Abstract]   [Full Text] [Related]  

  • 79. Nucleotide sequences at the 5'-linked ends of viral ribonucleic acids.
    Glitz DG; Bradley A; Fraenkel-Contrat H
    Biochim Biophys Acta; 1968 Jun; 161(1):1-12. PubMed ID: 5661372
    [No Abstract]   [Full Text] [Related]  

  • 80. Immunochemical studies on the tobacco mosaic virus protein. VII. The binding of octanoylated peptides of the tobacco mosaic virus protein with antibodies to the whole protein.
    Benjamini E; Shimizu M; Young JD; Leung CY
    Biochemistry; 1968 Apr; 7(4):1261-4. PubMed ID: 5663399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.